Arbutus Biopharma Corp.
(NASDAQ : ABUS)

( )
ABUS After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -8.85%186.610.0%$1817.38m
NVAXNovavax, Inc. -11.17%98.4478.2%$701.14m
AMGNAmgen, Inc. -0.65%233.831.4%$535.97m
BIIBBiogen, Inc. -2.29%233.811.8%$504.17m
GILDGilead Sciences, Inc. -1.87%70.431.0%$471.68m
BNTXBioNTech SE -13.66%169.230.0%$451.66m
REGNRegeneron Pharmaceuticals, Inc. -0.65%611.222.7%$396.18m
ILMNIllumina, Inc. -5.43%383.133.3%$385.62m
VRTXVertex Pharmaceuticals, Inc. -1.28%231.071.9%$334.21m
SNSSSunesis Pharmaceuticals, Inc. -5.36%3.000.7%$209.71m
EXASEXACT Sciences Corp. -1.29%77.4217.9%$154.16m
ARNAArena Pharmaceuticals, Inc. -0.72%91.9813.7%$145.42m
ALNYAlnylam Pharmaceuticals, Inc. -6.27%139.198.2%$139.12m
INCYIncyte Corp. 0.17%75.012.4%$132.91m
BMRNBioMarin Pharmaceutical, Inc. -3.89%86.714.2%$106.20m

Company Profile

Arbutus Biopharma Corp. is a biopharmaceutical company. It engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company was founded in 2007 and is headquartered in Warminster, PA.